Patents Assigned to Shanghai Institute of Pharmaceutical Indusrty
  • Publication number: 20110275671
    Abstract: Disclosed are dihydroindolone compounds which can modulate the activity of protein tyrosine kinases, a method for preparing the same, and pharmaceutical compositions comprising the same. Also disclosed are use of such compounds and pharmaceutical compositions thereof in the treatment and/or prophylaxis of protein tyrosine kinase associated diseases in an organism, particularly in the treatment and/or prophylaxis of tumors and fibroblast proliferation associated diseases.
    Type: Application
    Filed: May 25, 2009
    Publication date: November 10, 2011
    Applicant: Shanghai Institute of Pharmaceutical Indusrty
    Inventors: Zhedong Yuan, Xiaomin Zhang, Hubo Wang, Xueyan Zhu, Hongjiang Xu, Hui Fu, Wei Song